Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Dawn DiGiugno
Introduction
Dawn DiGiugno is a notable inventor based in Guilford, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target HIV. Her work is crucial in the ongoing fight against HIV infection and AIDS.
Latest Patents
Dawn DiGiugno holds a patent for a compound titled N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide. This invention encompasses a series of bicyclic pyrimidinone compounds that inhibit HIV integrase, preventing viral integration into human DNA. The compounds are designed to be useful for treating HIV infection and AIDS, and the patent also includes pharmaceutical compositions and methods for treating those infected with HIV.
Career Highlights
Dawn DiGiugno is associated with Bristol-Myers Squibb Company, where she has been able to apply her innovative ideas in a collaborative environment. Her work has led to advancements in the treatment of HIV, showcasing her dedication to improving public health.
Collaborations
Throughout her career, Dawn has worked alongside esteemed colleagues such as B Narasimhulu Naidu and Margaret E Sorenson. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Dawn DiGiugno's contributions to the field of HIV treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to have a positive impact on the lives of those affected by HIV and AIDS.